Skip to main content
Journal cover image

High-Sensitivity Troponin I and Coronary Computed Tomography in Symptomatic Outpatients With Suspected CAD: Insights From the PROMISE Trial.

Publication ,  Journal Article
Januzzi, JL; Suchindran, S; Coles, A; Ferencik, M; Patel, MR; Hoffmann, U; Ginsburg, GS; Douglas, PS; PROMISE Investigators,
Published in: JACC Cardiovasc Imaging
June 2019

OBJECTIVES: The goal of this study was to examine associations between concentrations of high-sensitivity troponin I (hsTnI) (measured by using a single-molecule counting method) and obstructive coronary artery disease (CAD) in 1,844 stable, symptomatic outpatients with suspected CAD randomized to undergo coronary computed tomography angiography (CTA) in the PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) trial. BACKGROUND: Elevated concentrations of hsTnI are associated with CAD in patients with myocardial infarction. The meaning of hsTnI concentrations in stable symptomatic outpatients is not well understood. METHODS: Clinical characteristics and CTA results (including coronary artery calcium [CAC] scores) were expressed across hsTnI quartiles. Determinants of hsTnI concentration were identified. Multivariable logistic regression identified independent predictors of obstructive CAD50 (≥50% stenosis in any vessel) and CAD70 (≥70% stenosis or ≥50% left main). RESULTS: The median hsTnI concentration was 1.5 ng/l; nearly all (98.5%) subjects had measurable hsTnI, and 6.1% had concentrations ≥99th percentile concentration for this assay (6 ng/l). Higher CAC scores, as well as more prevalent and diffuse CAD, was seen in upper hsTnI quartiles (all p < 0.001). Independent predictors of hsTnI concentrations included age, sex, and CAC score (all p < 0.05). After adjusting for demographic and clinical characteristics, log-transformed hsTnI concentrations were associated with obstructive CAD50 (odds ratio: 1.15 per interquartile range; p = 0.02) and CAD70 (odds ratio: 1.25 per interquartile range; p = 0.001). CONCLUSIONS: In stable symptomatic outpatients undergoing nonemergent coronary CTA for the diagnosis of suspected CAD, higher concentrations of hsTnI were associated with increasing presence and severity of coronary atherosclerosis. (Prospective Multicenter Imaging Study for Evaluation of Chest Pain [PROMISE]; NCT01174550).

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JACC Cardiovasc Imaging

DOI

EISSN

1876-7591

Publication Date

June 2019

Volume

12

Issue

6

Start / End Page

1047 / 1055

Location

United States

Related Subject Headings

  • Vascular Calcification
  • Up-Regulation
  • Troponin I
  • Severity of Illness Index
  • Risk Factors
  • Risk Assessment
  • Prognosis
  • Prevalence
  • Predictive Value of Tests
  • Outpatients
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Januzzi, J. L., Suchindran, S., Coles, A., Ferencik, M., Patel, M. R., Hoffmann, U., … PROMISE Investigators, . (2019). High-Sensitivity Troponin I and Coronary Computed Tomography in Symptomatic Outpatients With Suspected CAD: Insights From the PROMISE Trial. JACC Cardiovasc Imaging, 12(6), 1047–1055. https://doi.org/10.1016/j.jcmg.2018.01.021
Januzzi, James L., Sunil Suchindran, Adrian Coles, Maros Ferencik, Manesh R. Patel, Udo Hoffmann, Geoffrey S. Ginsburg, Pamela S. Douglas, and Pamela S. PROMISE Investigators. “High-Sensitivity Troponin I and Coronary Computed Tomography in Symptomatic Outpatients With Suspected CAD: Insights From the PROMISE Trial.JACC Cardiovasc Imaging 12, no. 6 (June 2019): 1047–55. https://doi.org/10.1016/j.jcmg.2018.01.021.
Januzzi JL, Suchindran S, Coles A, Ferencik M, Patel MR, Hoffmann U, et al. High-Sensitivity Troponin I and Coronary Computed Tomography in Symptomatic Outpatients With Suspected CAD: Insights From the PROMISE Trial. JACC Cardiovasc Imaging. 2019 Jun;12(6):1047–55.
Januzzi, James L., et al. “High-Sensitivity Troponin I and Coronary Computed Tomography in Symptomatic Outpatients With Suspected CAD: Insights From the PROMISE Trial.JACC Cardiovasc Imaging, vol. 12, no. 6, June 2019, pp. 1047–55. Pubmed, doi:10.1016/j.jcmg.2018.01.021.
Januzzi JL, Suchindran S, Coles A, Ferencik M, Patel MR, Hoffmann U, Ginsburg GS, Douglas PS, PROMISE Investigators. High-Sensitivity Troponin I and Coronary Computed Tomography in Symptomatic Outpatients With Suspected CAD: Insights From the PROMISE Trial. JACC Cardiovasc Imaging. 2019 Jun;12(6):1047–1055.
Journal cover image

Published In

JACC Cardiovasc Imaging

DOI

EISSN

1876-7591

Publication Date

June 2019

Volume

12

Issue

6

Start / End Page

1047 / 1055

Location

United States

Related Subject Headings

  • Vascular Calcification
  • Up-Regulation
  • Troponin I
  • Severity of Illness Index
  • Risk Factors
  • Risk Assessment
  • Prognosis
  • Prevalence
  • Predictive Value of Tests
  • Outpatients